| Company Name: |
Hangzhou Milestone Pharmtech Co., Ltd.
|
| Tel: |
0571-82896630 18969958410 |
| Email: |
sales_hz@milestonepharmtech.com |
| Products Intro: |
Product Name:2-{[(4-chloro-2,6-difluorophenyl)methyl]amino}-7-oxo-5-propyl-4H,7H-pyrazolo[1,5-a]pyrimidine-3-carbonitrile
CAS:1800024-45-6
Purity:95% Package:50；100；250；1000G
|
2-{[(4-chloro-2,6-difluorophenyl)methyl]amino}-7-oxo-5-propyl-4H,7H-pyrazolo[1,5-a]pyrimidine-3-carbonitrile manufacturers
- BCAT-IN-2
-
- $50.00 / 1mg
-
2024-11-12
- CAS:1800024-45-6
- Min. Order:
- Purity: 98.86%
- Supply Ability: 10g
|
| | 2-{[(4-chloro-2,6-difluorophenyl)methyl]amino}-7-oxo-5-propyl-4H,7H-pyrazolo[1,5-a]pyrimidine-3-carbonitrile Basic information |
| Product Name: | 2-{[(4-chloro-2,6-difluorophenyl)methyl]amino}-7-oxo-5-propyl-4H,7H-pyrazolo[1,5-a]pyrimidine-3-carbonitrile | | Synonyms: | 2-{[(4-chloro-2,6-difluorophenyl)methyl]amino}-7-oxo-5-propyl-4H,7H-pyrazolo[1,5-a]pyrimidine-3-carbonitrile;Pyrazolo[1,5-a]pyrimidine-3-carbonitrile, 2-[[(4-chloro-2,6-difluorophenyl)methyl]amino]-4,7-dihydro-7-oxo-5-propyl-;BCAT-IN-2;BCAT IN 2,BCATIN2;2-((4-Chloro-2,6-difluorobenzyl)amino)-7-oxo-5-propyl-4,7-dihydropyrazolo[1,5-a]pyrimidine-3-carbonitrile;BCAT-IN-2, 10 mM in DMSO | | CAS: | 1800024-45-6 | | MF: | C17H14ClF2N5O | | MW: | 377.78 | | EINECS: | | | Product Categories: | | | Mol File: | 1800024-45-6.mol | ![2-{[(4-chloro-2,6-difluorophenyl)methyl]amino}-7-oxo-5-propyl-4H,7H-pyrazolo[1,5-a]pyrimidine-3-carbonitrile Structure](CAS/20210111/GIF/1800024-45-6.gif) |
| | 2-{[(4-chloro-2,6-difluorophenyl)methyl]amino}-7-oxo-5-propyl-4H,7H-pyrazolo[1,5-a]pyrimidine-3-carbonitrile Chemical Properties |
| Boiling point | 545.0±60.0 °C(Predicted) | | density | 1.48±0.1 g/cm3(Predicted) | | pka | -1.46±0.40(Predicted) | | form | Solid | | color | White to yellow |
| | 2-{[(4-chloro-2,6-difluorophenyl)methyl]amino}-7-oxo-5-propyl-4H,7H-pyrazolo[1,5-a]pyrimidine-3-carbonitrile Usage And Synthesis |
| Uses | BCAT-IN-2 is a potent, selective and orally active inhibitor of mitochondrial branched-chain aminotransferase (BCATm), with a pIC50 of 7.3. BCAT-IN-2 shows selectivity for BCATm over BCATc (pIC50=6.6). BCAT-IN-2 can be used for the research of obesity and dislipidema[1]. | | in vivo | BCAT-IN-2 (compound 61) (10-100 mg/kg; p.o.) increases the level of leucine from 473 μM to 1.2 mM at the dose of 100 mg/kg in mice[1].
BCAT-IN-2 (5 mg/kg for p.o. and 1 mg/kg for i.v.) exhibits a high bioavailability (F=100%), long half-life (t1/2=9.2 h) and low clearance (Cl=0.3 mL/min/kg) in mice[1]. | | References | [1] Bertrand SM, et, al. The Discovery of in Vivo Active Mitochondrial Branched-Chain Aminotransferase (BCATm) Inhibitors by Hybridizing Fragment and HTS Hits. J Med Chem. 2015 Sep 24;58(18):7140-63. DOI:10.1021/acs.jmedchem.5b00313 |
| | 2-{[(4-chloro-2,6-difluorophenyl)methyl]amino}-7-oxo-5-propyl-4H,7H-pyrazolo[1,5-a]pyrimidine-3-carbonitrile Preparation Products And Raw materials |
|